Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?

To: SnowShredder who wrote (4294)	3/10/1998 6:10:00 AM
From: Rocketman	Read Replies (1) \| Respond to of 9719

No nothing of BEAM, but welcome aboard, now it is time for bed! Couldn't resist posting #4300 though. Rman

To: SnowShredder who wrote (4294)	3/10/1998 12:07:00 PM
From: Vector1	Respond to of 9719

Where'd He Go?, Nice name.:=,> I have been an investor in VISX for a while so I have some knowledge of the industry. BEAM (Summit Technologies) is a competitor of VISX. The two companies are the principals of Pillar Point Partners which is a vehicle for collecting royalties on certain laser procedures. The two companies have long sordid histories and have been suing each other on and off for years. VISX is professionally managed, has a huge cash horde and is by far the superior company. BEAM has been grossly mismanaged in the past although I must confess I have not reviewed current management. In the past the rocket scientists at BEAM tried to start their own eye surgery centers, something they had no experience in and therby directly competing with their customers. Not smart. i don't know whether they have divested that business. I have considered VISX for the model and in the past it has been a mediocre performer for me (I have an average cost of $21). Lately the stock has performed well and I am being rewarded for my patience. The procedures are safe and the rampup is accellerating. Maybe there is a lesson here for GENZL. Although I think both companies will benefit from the growing acceptance of laser eye surgery I would stay away from BEAM. My target on VISX is $40. V1